| The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun NR Sundaresan, P Vasudevan, L Zhong, G Kim, S Samant, V Parekh, ... Nature medicine 18 (11), 1643-1650, 2012 | 477 | 2012 |
| The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy NR Sundaresan, VB Pillai, D Wolfgeher, S Samant, P Vasudevan, ... Science signaling 4 (182), ra46-ra46, 2011 | 355 | 2011 |
| l-2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer EH Shim, CB Livi, D Rakheja, J Tan, D Benson, V Parekh, EY Kho, ... Cancer discovery 4 (11), 1290-1298, 2014 | 275 | 2014 |
| Inositol-and folate-resistant neural tube defects in mice lacking the epithelial-specific factor Grhl-3 SB Ting, T Wilanowski, A Auden, M Hall, AK Voss, T Thomas, V Parekh, ... Nature medicine 9 (12), 1513-1519, 2003 | 204 | 2003 |
| A highly conserved novel family of mammalian developmental transcription factors related to Drosophila grainyhead T Wilanowski, A Tuckfield, L Cerruti, S O'Connell, R Saint, V Parekh, J Tao, ... Mechanisms of development 114 (1-2), 37-50, 2002 | 195 | 2002 |
| Regional neural tube closure defined by the Grainy head-like transcription factors Y Rifat, V Parekh, T Wilanowski, NR Hislop, A Auden, SB Ting, ... Developmental biology 345 (2), 237-245, 2010 | 139 | 2010 |
| The unique and cooperative roles of the Grainy head-like transcription factors in epidermal development reflect unexpected target gene specificity Y Boglev, T Wilanowski, J Caddy, V Parekh, A Auden, C Darido, ... Developmental biology 349 (2), 512-522, 2011 | 126 | 2011 |
| Cutaneous squamous cell carcinoma V Parekh, JT Seykora Clinics in laboratory medicine 37 (3), 503-525, 2017 | 123 | 2017 |
| Biochemical and epigenetic insights into L-2-hydroxyglutarate, a potential therapeutic target in renal cancer S Shelar, EH Shim, GJ Brinkley, A Kundu, F Carobbio, T Poston, J Tan, ... Clinical Cancer Research 24 (24), 6433-6446, 2018 | 68 | 2018 |
| Mammary analogue secretory carcinoma TM Stevens, V Parekh Archives of pathology & laboratory medicine 140 (9), 997-1001, 2016 | 64 | 2016 |
| Bridging Cancer Biology with the Clinic: Relative Expression of a GRHL2-Mediated Gene-Set Pair Predicts Breast Cancer Metastasis X Yang, P Vasudevan, V Parekh, A Penev, JM Cunningham PloS one 8 (2), e56195, 2013 | 56 | 2013 |
| Defective extraembryonic angiogenesis in mice lacking LBP-1a, a member of the grainyhead family of transcription factors V Parekh, A McEwen, V Barbour, Y Takahashi, JE Rehg, SM Jane, ... Molecular and cellular biology 24 (16), 7113-7129, 2004 | 44 | 2004 |
| A microscopic landscape of the invasive breast cancer genome Z Ping, Y Xia, T Shen, V Parekh, GP Siegal, IE Eltoum, J He, D Chen, ... Scientific reports 6 (1), 27545, 2016 | 40 | 2016 |
| CD123 immunohistochemistry for plasmacytoid dendritic cells is useful in the diagnosis of scarring alopecia K Fening, V Parekh, K McKay Journal of cutaneous pathology 43 (8), 643-648, 2016 | 31 | 2016 |
| Whole-exome and transcriptome analysis of UV-exposed epidermis and carcinoma in situ reveals early drivers of carcinogenesis Q Zheng, BC Capell, V Parekh, C O’Day, C Atillasoy, HM Bashir, C Yeh, ... Journal of Investigative Dermatology 141 (2), 295-307. e13, 2021 | 30 | 2021 |
| A histological snapshot of hypothetical multistep progression from nevus sebaceus to invasive syringocystadenocarcinoma papilliferum V Parekh, CE Guerrero, CF Knapp, CA Elmets, KM McKay The American Journal of Dermatopathology 38 (1), 56-62, 2016 | 30 | 2016 |
| Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T‐cell lymphoma: a retrospective single‐centre case series* NA Trum, J Zain, XU Martinez, V Parekh, M Afkhami, F Abdulla, ... British Journal of Dermatology 186 (1), 153-166, 2022 | 29 | 2022 |
| cDNA cloning and regulation of two sex-hormone-repressed hamster tear lipocalins having homology with odorant/pheromone-binding proteins S Srikantan, V Parekh, PK De Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression 1729 (3 …, 2005 | 26 | 2005 |
| L-2-Hydroxyglutarate: An epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov. 2014; 4: 1290–1298. doi: 10.1158/2159-8290 EH Shim, CB Livi, D Rakheja, J Tan, D Benson, V Parekh, EY Kho, ... CD-13-0696.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 22 | |
| Primary cutaneous CD30+ lymphoproliferative disorders: a comprehensive review C Di Raimondo, V Parekh, JY Song, ST Rosen, C Querfeld, J Zain, ... Current Hematologic Malignancy Reports 15, 333-342, 2020 | 21 | 2020 |
